Main > A1. CORP. INDEX. S-Sm > Scripps Research Institute/P C2



Scripps Research Institute/P C2's subsections

2000. 10.02.2000. (Target. RNA)
2000. 10.09.2000. (MultiValency)
2001. 01.08.2001. (Oncology)
2001. 04.09.2001. (OligoSaccharide)
2002. 04.01.2002. (Chem. Dep.)
2002. 05.13.2002. (Epothilone)
2002. 06.03.2002. (Chiral Compd)
2002. 07.01.2002. (Oncology)
2002. 07.22.2002. (BioTech Patent)
2002. 08.05.2002. (BioEngg.)
2002. 11.04.2002. (Oncology)
2002. 11.25.2002. (Ab/O3..)
2002. 11.25.2002. (Genetic Disease)
2002. 11.25.2002. (Sepsis Vaccine)
2003. 01.13.2003. (Comments)
2003. 01.20.2003. (E. Coli/21st AA)
2003. 03.29.2003. (Organics)
2003. 07.22.2003. (Click Chemistry)
2003. 09.01.2003. (Comments)
2003. 10.27.2003. (Antibiotics)
2003. 10.27.2003. (CombiChem/MCR)
2003. 11.10.2003. (Cardiology)
2003. 11.17.2003. (Catalysis)
2004. 02.16.2004. (Click Chemistry)
2004. 02.16.2004. (DNA Folding)
2004. 03.19.2004. (AD/Inflammation)
2004. 08.09.2004. (OligoSaccharide)
2005. 02.21.2005. (Peptide CycloDim
2005. 05.16.2005. (Antibiotics)
2005. 05.30.2005. (Garlic Heat)
2005. 10.10.2005. (Protein Target)
2006. 02.13.2006. (Antibiotics)
2006. 03.20.2006. (Oncology)
2008. 03.24.2008. (Vinigrol)
2008. 05.26.2008. AntiAngiogenic
2008. 10.06.2008. AIDS Vaccine
2012. 01.02.2012. Pres.
2012. 04.18.2012. Cocaine
2014. 04.14. Scripps Advance
Functional Glycomics Gateway C2
Patents
Web-Site

Scripps Research Institute/P C2's products
This section has no products